
LoRezTrader
@loreztrader
LT B&H investor taking occasional swings. Focus on disruptive, transformational bets w/ potential to 5-10x+. Med/biotech, SaaS, e-comm, space, crypto/web 3.0
ID: 1268056293241245696
03-06-2020 05:46:30
11,11K Tweet
2,2K Followers
494 Following

CHOP & Penn Medicine have delivered the first-ever personalized gene editing therapy for a patient with CPS1 deficiency, marking a major milestone in the application of CRISPR-based treatments. Learn more about KJ & the future of personalized medicine: ms.spr.ly/6015SZLAx.















I was honored to host the inaugural Richard Slayman Clinical #Xenotransplantation Workshop Mass General Mass General Transplant Mass General Brigham Nephrology honoring the world’s first recipient of a gene-edited pig kidney🧬🐷140+ experts from academia,biotech ® agencies joined to shape the future Xeno




